Concepedia

K. Raja Reddy

KR

Statistics

Publications

23

Citations

1.3K

H-Index

17

Active since

1987

Affiliations

Torrey Pines Institute For Molecular Studies(Current)

Harvard University

University of Hyderabad

Mapp Biopharmaceutical (United States)

Fate Therapeutics (United States)

K. Raja Reddy is an author at Torrey Pines Institute For Molecular Studies specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

1987–2021

23

Publications

23

Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases

Scott J. Hecker, K. Raja Reddy, Olga Lomovskaya et al. · Journal of Medicinal Chemistry · 2020 · 212 citations · Full text

, , +17

MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes

Mark D. Erion, Paul D. van Poelje, Qun Dang et al. · Proceedings of the National Academy of Sciences · 2005 · 162 citations

, , +17

Design, Synthesis, and Characterization of a Series of Cytochrome P<sub>450</sub>3A-Activated Prodrugs (HepDirect Prodrugs) Useful for Targeting Phosph(on)ate-Based Drugs to the Liver<sup>§</sup>

Mark D. Erion, K. Raja Reddy, Serge H. Boyer et al. · Journal of the American Chemical Society · 2004 · 160 citations

, , +17

Total synthesis of hemibrevetoxin B and (7a.alpha.)-epi-hemibrevetoxin B

K. C. Nicolaou, K. Raja Reddy, G. SKOKOTAS et al. · Journal of the American Chemical Society · 1993 · 116 citations

, , +7

Discovery of Potent and Specific Fructose-1,6-Bisphosphatase Inhibitors and a Series of Orally-Bioavailable Phosphoramidase-Sensitive Prodrugs for the Treatment of Type 2 Diabetes

Qun Dang, Srinivas Rao Kasibhatla, K. Raja Reddy et al. · Journal of the American Chemical Society · 2007 · 97 citations

, , +17

1–5 of 23